← Back to Search

Exercise Prehabilitation for Pancreatic Cancer (PREHAB Trial)

N/A
Recruiting
Led By Philip Chang, DO
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Physically able to complete functional assessments including 6-minute walk test, hand grip strength, short performance physical battery, and performance metrics
Pancreatic cancer diagnosis (any stage)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 3 months
Awards & highlights

PREHAB Trial Summary

This trial tests if an exercise program can help people with pancreatic cancer.

Who is the study for?
This trial is for English-speaking adults with pancreatic cancer who can walk and do daily activities on their own. They must be able to perform certain physical tests, have no major restrictions on exercise from their doctor, give written consent, and use a smart device for activity tracking. People who've had or will have surgery before the program ends, are pregnant, or use certain electronic medical devices can't join.Check my eligibility
What is being tested?
The study is testing an exercise program called PREHAB for people with pancreatic cancer. It aims to see if this supervised prehabilitation helps improve patients' fitness levels and overall well-being before they undergo any other treatments.See study design
What are the potential side effects?
Since the intervention involves an exercise program, potential side effects may include typical risks associated with physical activity such as muscle soreness, fatigue, or injury. The specific side effects will depend on each participant's health condition.

PREHAB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can perform physical tests like walking, gripping, and other short exercises.
Select...
I have been diagnosed with pancreatic cancer.
Select...
I can walk and take care of my daily needs on my own.
Select...
I can sync a Fitbit and use www.painguide.com on my smart device.
Select...
I am 18 years old or older.

PREHAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PREHAB Program feasibility will be measured by tracking participant attendance at PREHAB sessions. PREHAB will be considered feasible if 50% of participants attend at least 60% of scheduled sessions.
Secondary outcome measures
PREHAB Program safety will be assessed through the reporting of unanticipated problems from the baseline visit through to the 3 Month visit.

PREHAB Trial Design

1Treatment groups
Experimental Treatment
Group I: Supervised Prehabilitation Exercise ProgramExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
497 Previous Clinical Trials
164,543 Total Patients Enrolled
Philip Chang, DOPrincipal InvestigatorCedars-Sinai Medical Center
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Prehabilitation Program Clinical Trial Eligibility Overview. Trial Name: NCT05692323 — N/A
Pancreatic Cancer Research Study Groups: Supervised Prehabilitation Exercise Program
Pancreatic Cancer Clinical Trial 2023: Prehabilitation Program Highlights & Side Effects. Trial Name: NCT05692323 — N/A
Prehabilitation Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05692323 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open for this medical research endeavor?

"The information on clinicaltrials.gov discloses that this medical experiment is not currently recruiting patients, though it was originally opened for enrollment on April 1st 2023. The last update to the study occurred on January 11th 2023 and there are 694 other trials actively enrolling participants at present."

Answered by AI
~0 spots leftby Apr 2024